These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1113128)

  • 1. A rapid fluorescence microscopic method for the study of the capillary DOPA-dopamine barrier.
    Jancsó G
    J Neurochem; 1975 Mar; 24(3):579-80. PubMed ID: 1113128
    [No Abstract]   [Full Text] [Related]  

  • 2. Passage into the rat brain of dopa and dopamine injected into the lateral ventricle.
    Constantinidis J; Gaillard JM; Geissbuhler F; Tissot R
    Br J Pharmacol; 1971 Sep; 43(1):32-8. PubMed ID: 5136462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Animal models for an enzymic blood-brain barrier mechanism for therapeutically administered L-dopa.
    Dowson JH
    Life Sci; 1973 Jul; 13(1):23-9. PubMed ID: 4753023
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopamine formation in brain capillaries--an enzymic blood-brain barrier mechanism.
    Owman C; Rosengren E
    J Neurochem; 1967 May; 14(5):547-50. PubMed ID: 6025622
    [No Abstract]   [Full Text] [Related]  

  • 5. Accumulation of dopamine in the parenchyma after decarboxylase inhibition in the capillaries of brain.
    Constantinidis J; Bartholini G; Tissot R; Pletscher A
    Experientia; 1968 Feb; 24(2):130-1. PubMed ID: 5643797
    [No Abstract]   [Full Text] [Related]  

  • 6. Relative penetration of L-dopa and 5-HTP through the brain barrier using dimethyl sulfoxide.
    De la Torre JC
    Experientia; 1970 Oct; 26(10):1117-8. PubMed ID: 5312418
    [No Abstract]   [Full Text] [Related]  

  • 7. [The capillary barrier for dopa in brain and different organs].
    Constantinidis J; De La Torre JC; Tissot R; Geissbuhler F
    Psychopharmacologia; 1969; 15(2):75-87. PubMed ID: 5351123
    [No Abstract]   [Full Text] [Related]  

  • 8. [The capillary enzyme barrier for DOPA at the level of some brain stem nuclei in the rat].
    Constantinidis J; Bartholini G; Geissbühler F; Tissot R
    Experientia; 1970 Apr; 26(4):381-3. PubMed ID: 5439606
    [No Abstract]   [Full Text] [Related]  

  • 9. THE DIRECT DEMONSTRATION OF A BARRIER MECHANISM IN THE BRAIN CAPILLARIES.
    BERTLER A; FALCK B; ROSENGREN E
    Acta Pharmacol Toxicol (Copenh); 1963; 20():317-21. PubMed ID: 14162814
    [No Abstract]   [Full Text] [Related]  

  • 10. Brain capillaries as a source of homovanillic acid in cerebrospinal fluid.
    Bartholini G; Tissot R; Pletscher A
    Brain Res; 1971 Mar; 27(1):163-8. PubMed ID: 5554221
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of reserpine and prenylamine on the L-dopa turnover in the rat exocrine pancreas.
    Alm P; Ehinger B; Falck B; Nordgren L
    Eur J Pharmacol; 1971 Oct; 16(2):192-200. PubMed ID: 5161258
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental evaluation of L-dopa penetration in brain.
    De la Torre JC; Mullan S
    Trans Am Neurol Assoc; 1971; 96():227-9. PubMed ID: 5159088
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative evaluation of the blood-brain barrier capacity to form dopamine from circulating L-DOPA.
    Hardebo JE; Edvinsson L; Owman C; Rosengren E
    Acta Physiol Scand; 1977 Mar; 99(3):377-84. PubMed ID: 848309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central decarboxylation and uptake of L-DOPA.
    Andén NE; Engel J; Rubenson A
    Naunyn Schmiedebergs Arch Pharmacol; 1972; 273(1):11-26. PubMed ID: 4260798
    [No Abstract]   [Full Text] [Related]  

  • 15. [Changes in the cellular efflux of catecholamines due to neuroleptics and tricyclic antidepressants].
    Constatinidis J
    Bull Schweiz Akad Med Wiss; 1974 Jul; 30(1-3):66-81. PubMed ID: 4422377
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of pilocarpine on L-dopa turnover in the exocrine rat pancreas.
    Alm P
    Acta Physiol Scand; 1971 Oct; 83(2):269-77. PubMed ID: 5114364
    [No Abstract]   [Full Text] [Related]  

  • 17. Participation of dopamine- and serotonin- receptors in the disaggregation of brain polysomes by L-dopa and L-5-HTP.
    Weiss BF; Liebschutz JL; Wurtman RJ; Munro HN
    J Neurochem; 1975 Jun; 24(6):1191-5. PubMed ID: 1079238
    [No Abstract]   [Full Text] [Related]  

  • 18. Behavioral, biochemical, and histochemical analyses of the central effects of monoamine precursors after peripheral decarboxylase inhibition.
    Butcher LL; Engel J; Fuxe K
    Brain Res; 1972 Jun; 41(2):387-411. PubMed ID: 4402607
    [No Abstract]   [Full Text] [Related]  

  • 19. Recent advances in the treatment of Parkinsonism with drugs.
    Rinne UK
    Acta Neurol Scand Suppl; 1972; 51():59-103. PubMed ID: 4576076
    [No Abstract]   [Full Text] [Related]  

  • 20. DOPA effects on motility in mice; potentiation by MK 485 and dexchlorpheniramine.
    Strömberg U
    Psychopharmacologia; 1970 Aug; 18(1):58-67. PubMed ID: 5535577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.